OptiBiotix Health (LON:OPTI – Get Free Report) posted its quarterly earnings data on Thursday. The company reported GBX (1.52) earnings per share (EPS) for the quarter, Digital Look Earnings reports. OptiBiotix Health had a negative return on equity of 52.92% and a negative net margin of 333.62%.
OptiBiotix Health Stock Performance
LON OPTI opened at GBX 6 on Thursday. The firm has a 50-day simple moving average of GBX 5.80 and a 200 day simple moving average of GBX 5.74. OptiBiotix Health has a twelve month low of GBX 4.50 and a twelve month high of GBX 12.25. The stock has a market cap of £6.20 million, a PE ratio of -1.56 and a beta of 1.82.
About OptiBiotix Health
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products.
Featured Articles
- Five stocks we like better than OptiBiotix Health
- This Gold ETF Turns a Non-Yielding Asset Into Monthly Income—But There’s a Catch
- Analysts See Double-Digit Upside for These 3 Stocks
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
